2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines

Details 2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines 2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines

1986-02-10

1988-09-06

Daus, Donald G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

540586, A61K 3155, C07D22332

Patent

active

047693681

ABSTRACT:
2,3,4,8,9,9a-Hexahydro-4-aryl-1H-indeno[1,7-cd;]-azepines are selective dopamine receptor site binding agents.

REFERENCES:
patent: 4104379 (1978-08-01), Gallagher, Jr. et al.
patent: 4111957 (1978-09-01), Holden et al.
patent: 4197297 (1980-04-01), Weinstock
patent: 4284555 (1981-08-01), Gold et al.
Chemical Abstracts, vol. 79, No. 5, Aug. 6, 1973.
Chemical Abstracts, vol. 84, No. 7, Feb. 16, 1976.
Flaim, K. E. et al., Binding of a Novel Dopaminergic Agonist Radioligand [.sup.3 H]-Fenoldopam.sup.1 (SK&F 82526) to D-1 Receptors in Rat Striatum, Life Sci., 36:1427-36 (1985).
Van Rooyen, J. M. and J. Offermeier, Peripheral Dopaminergic Receptors, S. Afr. Med. J., 59:329-32 (1981).

Affiliated with

Also associated with

Rating

2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1606950